Epiloid Biotechnology

Neuropharmaceutical Assessment in Human Brain Organoids

Neuropharmaceutical Assessment in

Human Brain Organoids

Neuropharmaceutical Assessment

in Human Brain Organoids

Epiloid predicts preclinical drug

efficacy through analysis of human brain organoids

Epiloid predicts preclinical drug

efficacy through analysis of human brain organoids

Learn More

De-Risking Neurological Drug Development

<6%

of neurology drugs go to market

Preclinical models fail to replicate

human toxicity or efficacy

$0.8 - 1.6 B

is spent per failed drug candidate